SEELOS THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Seelos Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Seelos Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.14M, a 71.3% increase year-over-year.
  • Seelos Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$29.8M, a 46.3% increase year-over-year.
  • Seelos Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$40.5M, a 42.9% increase from 2022.
  • Seelos Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$70.9M, a 15% decline from 2021.
  • Seelos Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$61.7M, a 229% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$29.8M -$3.14M +$7.81M +71.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$37.6M -$6.06M +$2.88M +32.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$40.5M -$8.01M +$10.2M +56.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 -$50.7M -$12.6M +$4.81M +27.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$55.6M -$11M +$10.3M +48.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$65.8M -$8.93M +$5.08M +36.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$70.9M -$18.3M +$9.12M +33.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 -$80M -$17.4M -$6.5M -59.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$73.5M -$21.2M -$14.5M -214% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$59.1M -$14M +$2.6M +15.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$61.7M -$27.4M -$21.5M -368% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 -$40.1M -$10.9M -$6.83M -167% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$33.3M -$6.77M -$3.45M -104% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$29.9M -$16.6M -$11.1M -202% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$18.8M -$5.85M +$4.49M +43.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-04
Q3 2020 -$23.2M -$4.09M -$404K -11% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$22.8M -$3.32M +$74K +2.18% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$22.9M -$5.51M +$6.83M +55.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 -$29.7M -$10.3M -$9.29M -893% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$20.5M -$3.68M -$2.59M -239% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$17.9M -$3.39M -$2.97M -706% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$14.9M -$12.3M -$11.7M -1841% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$3.18M -$1.04M +$1.63M +61% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-17
Q3 2018 -$4.81M -$1.09M +$2.63M +70.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$7.44M -$421K +$2.02M +82.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$9.46M -$636K +$1.22M +65.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-21
Q4 2017 -$10.7M -$2.67M -$164K -6.56% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 -$10.5M -$3.72M -$2M -116% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 -$8.52M -$2.44M +$2.18M +47.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$10.7M -$1.85M +$2.97M +61.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$13.7M -$2.5M +$1.01M +28.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$14.7M -$1.72M +$4.17M +70.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$18.9M -$4.63M +$1.2M +20.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$20.1M -$4.83M +$1.3M +21.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$21.4M -$3.51M +$13.6M +79.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-13
Q3 2015 -$34.9M -$5.89M -$2.71M -85.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$32.2M -$5.82M -$7.07M -568% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$25.1M -$6.12M -$2.58M -72.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$22.6M -$17.1M -$13.1M -328% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$9.47M -$3.18M -$19K -0.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$9.45M $1.25M +$5.3M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$14.7M -$3.54M +$2.62M +42.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$17.4M -$3.99M +$10.6M +72.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-09
Q3 2013 -$28M -$3.16M -$838K -36% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$27.2M -$4.05M +$294K +6.76% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$27.5M -$6.16M -$2.45M -66% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$25M -$14.6M -$9.82M -204% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 -$15.2M -$2.33M -$96.9K -4.35% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$15.1M -$4.35M +$3.48M +44.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$18.6M -$3.71M -$287K -8.39% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$18.3M -$4.8M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 -$2.23M +$322K +12.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 -$7.83M -$5.16M -193% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$3.42M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$2.55M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$2.67M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.